.After announcing a phase 3 launch based upon favorable midstage results, iTeos and also GSK are act...
.The FDA needs to be much more available as well as collective to discharge a rise in commendations ...
.It is actually an unusually busy Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Reha...
.Atea Pharmaceuticals' antiviral has failed an additional COVID-19 trial, however the biotech still ...
.Neurocrine Biosciences' schizophrenia program pivot has actually stopped working. The biotech was n...
.Sanofi has actually brought in an overdue entry to the radioligand party, paying 100 million euros ...
.After F2G's very first effort to obtain a brand-new course of antifungal to market was thwarted by ...
.Moderna has actually vowed to cut R&D costs by $1.1 billion through 2027. The selection to retra...
.Merely four months after Sanofi bet $80 thousand in beforehand money on Key Therapeutics' losmapimo...
.Cancer provider Oncternal Therapies is folding all its own clinical tests as well as giving up pers...